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Abstract: This paper looks at the opinions of 241 European academics (who provide pharmacy
education), and of 258 European community pharmacists (who apply it), on competences for
pharmacy practice. A proposal for competences was generated by a panel of experts using Delphi
methodology. Once finalized, the proposal was then submitted to a large, European-wide community
of academics and practicing pharmacists in an additional Delphi round. Academics and community
pharmacy practitioners recognized the importance of the notion of patient care competences,
underlining the nature of the pharmacist as a specialist of medicines. The survey revealed certain
discrepancies. Academics placed substantial emphasis on research, pharmaceutical technology,
regulatory aspects of quality, etc., but these were ranked much lower by community pharmacists who
concentrated more on patient care competences. In a sub-analysis of the data, we evaluated how
perceptions may have changed since the 1980s and the introduction of the notions of competence and
pharmaceutical care. This was done by splitting both groups into respondents < 40 and > 40 years old.
Results for the subgroups were essentially statistically the same but with some different qualitative
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tendencies. The results are discussed in the light of the different conceptions of the professional
identity of the pharmacist.
Keywords: education; academic; practice
1. Introduction
There have been a number of changes in pharmacy education over the past 20 years starting
firstly with the introduction of the concept of “competence for practice”. In 1974 there were two
publications in pharmacy education with the word “competence” in the title, in 2013 there were
66 [1]. Numerous frameworks have been proposed for the development and monitoring of pharmacy
practice based such competence frameworks [2–5]. Several studies have shown that such competence
frameworks can be successfully used to improve performance in community pharmacists [6,7].
However, little attention has been paid to the use of, and attitudes to, competence frameworks
in pre-graduate, pre-registration university education. Therefore, in order to assess the relevance of
pharmacy competencies, this study used the PHAR-QA “Quality Assurance in European Pharmacy
Education and Training” [8] project to look at the attitudes of academics and practicing community
pharmacists to the competences required for pharmacy practice.
A second change in pharmacy education over the past 20 years concerns the notion of
pharmaceutical care. Pharmaceutical care is the responsible provision of drug therapy for the purpose
of achieving outcomes that improve a patient’s quality of life. It is englobed in a wider notion of
patient care that refers to services rendered by healthcare professionals, and non-professionals under
their supervision, for the benefit of the patient.
The number of articles published that have “pharmaceutical care” in the title has risen from one
in 1960 to 210 in 2008 (see reference to Web of Science cited previously). This rise is similar to the rise in
the interest in the notion of competence described in the previous paragraph. In a post-hoc sub-analysis,
therefore, we looked at attitudes to competences in age sub-groups (< 40 and > 40 years old). It could
be expected that the younger age subgroup will have been much more exposed to the changes outlined
above than the older age subgroup.
2. Experimental Section
To evaluate academics’ attitudes to competences we asked academics in European pharmacy
departments to rank 68 competences for pharmacy practice. Results were compared to those obtained
from practicing community pharmacists.
The numbers of respondents are statistically representative of the overall European populations
(academics 10,000, community pharmacists 400,000 [9]). Respondents came from 36 different countries
and although not representing a homogenous population, it was a representative selection including
all significant subgroups (age, profession, region, etc.).
The methodology employed has been described in detail elsewhere (PHAR-QA reference cited
above). The main steps are shown in Table 1.
In order to check for any possible evolution in attitudes, in a sub-analysis we compared results
from 2 different age subgroups: < 40 and > 40 years of age. It is to be expected that the younger
age subgroup would have been more exposed to the introduction of the concepts of competence and
patient care than the older age subgroup.
GraphPad software was used for statistical analysis (ref).
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Table 1. The PHAR-QA “Quality Assurance in European Pharmacy Education and Training”
study methodology.
Step Phase
1
A competence framework based on published frameworks for healthcare specialists was
produced by 3 rounds of a Delphi process with an expert panel consisting of the authors of this
paper, 10/13 of whom practice as pharmacists (in addition to their academic employment).
2
The competences for practice produced after the 3rd Delphi round, were ranked by a large,
European-wide population of academics and community pharmacists using the PHAR-QA
surveymonkey [10] questionnaire. Respondents came from 36/49 countries of the European Higher
Education Area [11].
3 The first 6 questions were on the profile of the respondent (age, duration of practice, country ofresidence, current occupation (academic, community pharmacist)).
4
Questions 7 through 19 asked respondents to rank 68 competences arranged in 13 clusters of (see
annex). Questions in clusters 7 (numbering succeeding the 6th question of the responder profile)
through 11 were concerned with personal competences, and in clusters 12 through 19 with patient
care competences.
5
Respondents were asked to rank the proposals for competences on a 4-point Likert scale:
1. Not important = Can be ignored;
2. Quite important = Valuable but not obligatory;
3. Very important = Obligatory, with exceptions depending upon field of pharmacy practice;
4. Essential = Obligatory.
There was also a “cannot rank” possibility as well as the possibility of leaving an answer blank.
6
Ranking scores were calculated as (frequency rank 3 + frequency rank 4) as % of total frequency;
this represents the percentage of respondents that considered a given competence as “obligatory”.
This calculation is based on that used by the MEDINE (Medical Education in Europe) consortium
that ranked the competences for medical practice [12].
7
Leik ordinal consensus [13] was calculated as an indication of the dispersion of the data.
Responses for consensus were arbitrarily classified as: < 0.2 poor, 0.21–0.4 fair, 0.41–0.6 moderate,
0.61–0.8 substantial, > 0.81 good, as in the MEDINE study.
8 The statistical significance of differences amongst groups was estimated from the chi-square teston the ranking frequencies; a significance level of 5% was chosen.
9
Respondents could also comment on their ranking. An attempt was made to analyze comments
using the NVivo10 program [14] for the semi-quantitative analysis of unstructured data. In this
case, the numbers were too small to draw significant conclusions (results not shown).
3. Results and Discussion
The overall rankings by academics and community pharmacists, given in Table 2, were similar.
Table 2. Overall distribution (n = 68 competences) of rankings by academics and
community pharmacists.
Ranks Academics Community Pharmacists
Number of respondents 241 258
Theoretical number of replies 16,388 (= 241 respondents ˆ 68 competences) 17,544 (= 258 ˆ 68)
Rank Number % Number %
4 5821 38.6 6643 37.9
3 6005 39.6 6002 34.2
2 2982 19.7 3076 17.5
1 366 4.6 608 3.5
Cannot rank + blanks 1214 8.0 1215 6.9
Score (%) = ((5821 + 6005)/15,174) ˆ 100) = 77.9 = [(6643 + 6002)/16,3029] ˆ 100 = 77.4
Leik ordinal consensus 0.58 0.55
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Seven to eight percent of respondents in both groups were not able to rank all competences.
This suggests that the vast majority of respondents considered they had sufficient experience to reply
to all the questions asked.
As judged from the Leik ordinal consensus values, dispersion was low. Leik ordinal consensus for
rankings of individual competences ranged from 0.51 to 0.68 for academics, and from 0.42 to 0.71 for
community pharmacists. This suggests that opinions in both groups were relatively homogeneous, and
that subgroups with distributions of responses concerning the 68 competences significantly different
from that of the overall group do not exist. Similar values for ordinal consensus were reported by the
MEDINE “Medical Education in Europe” consortium. It further suggests that there are no differences
between age subgroups.
Scores for individual competences, given in Table 3, differed.
Table 3. Ranking of competences (score of validated competences as important (rank 3 or 4), %) by
academics and community pharmacists (n: sequential numbering).
Cluster n Competence Academics CommunityPharmacists
Cluster 7. Personal
competences:
learning and
knowledge.
1
Ability to identify learning needs and to learn
independently (including continuous professional
development (CPD)).
93.7 89.8
2
Analysis: ability to apply logic to problem solving,
evaluating pros and cons and following up on the
solution found.
94.5 91.1
3 Synthesis: capacity to gather and critically appraiserelevant knowledge and to summarize the key points. 92.8 87.9
4 Capacity to evaluate scientific data in line with currentscientific and technological knowledge. 87.3 75.8
5
Ability to interpret preclinical and clinical
evidence-based medical science and apply the
knowledge to pharmaceutical practice.
81.2 75.9
6 Ability to design and conduct research usingappropriate methodology. 65.4 40.2
7 Ability to maintain current knowledge of relevantlegislation and codes of pharmacy practice. 86.3 91.7
Cluster 8. Personal
competences:
values.
8 Demonstrate a professional approach to tasks andhuman relations. 91.5 94.5
9 Demonstrate the ability to maintain confidentiality. 92.3 95.3
10 Take full personal responsibility for patient care andother aspects of one’s practice. 88.3 94.8
11 Inspire the confidence of others in one's actionsand advice. 83.8 88.8
12 Demonstrate high ethical standards. 95.3 95.2
Cluster 9. Personal
competences:
communication and
organizational
skills.
13 Effective communication skills (both orally and written). 93.5 94.8
14 Effective use of information technology. 83.8 86.1
15 Ability to work effectively as part of a team. 83.3 89.2
16
Ability to identify and implement legal and professional
requirements relating to employment (e.g., for pharmacy
technicians) and to safety in the workplace.
77.9 81.0
17 Ability to contribute to the learning and training of staff. 79.6 82.5
18 Ability to design and manage the developmentprocesses in the production of medicines. 60.0 43.2
19 Ability to identify and manage risk and quality ofservice issues. 76.1 79.2
20 Ability to identify the need for new services. 61.8 64.5
21 Ability to communicate in English and/or locallyrelevant languages. 79.6 74.1
22 Ability to evaluate issues related to quality of service. 71.0 77.9
23 Ability to negotiate, understand a businessenvironment and develop entrepreneurship. 46.4 64.1
Pharmacy 2016, 4, 12 5 of 12
Table 3. Cont.
Cluster n Competence Academics CommunityPharmacists
Cluster 10. Personal
competences:
knowledge of
different areas of
the science of
medicines.
24 Plant and animal biology. 31.1 39.3
25 Physics. 25.6 21.7
26 General and inorganic chemistry. 45.6 43.9
27 Organic and medicinal/pharmaceutical chemistry. 80.2 66.0
28 Analytical chemistry. 60.0 41.9
29 General and applied biochemistry (medicinaland clinical). 74.2 68.8
30 Anatomy and physiology; medical terminology. 75.8 88.7
31 Microbiology. 67.0 72.2
32 Pharmacology including pharmacokinetics. 95.6 94.7
33 Pharmacotherapy and pharmaco-epidemiology. 92.5 94.3
34 Pharmaceutical technology including analyses ofmedicinal products. 89.0 62.0
35 Toxicology. 84.4 74.0
36 Pharmacognosy. 52.9 66.5
37 Legislation and professional ethics. 88.8 89.5
Cluster 11. Personal
competences:
understanding of
industrial
pharmacy.
38
Current knowledge of design, synthesis, isolation,
characterization and biological evaluation of
active substances.
57.5 41.7
39 Current knowledge of good manufacturing practice(GMP) and of good laboratory practice (GLP). 75.4 59.4
40 Current knowledge of European directives onqualified persons (QPs). 59.2 43.7
41 Current knowledge of drug registration, licensingand marketing. 72.1 55.7
42 Current knowledge of good clinical practice (GCP). 68.2 64.5
Cluster 12. Patient
care competences:
patient consultation
and assessment.
43 Ability to perform and interpret medical laboratory tests. 65.3 65.5
44
Ability to perform appropriate diagnostic or
physiological tests to inform clinical decision making e.g.,
measurement of blood pressure.
64.5 73.6
45
Ability to recognize when referral to another member of
the healthcare team is needed because a potential clinical
problem is identified (pharmaceutical, medical,
psychological or social).
89.1 91.7
Cluster 13. Patient
care competences:
need for drug
treatment
46 Retrieval and interpretation of relevant information onthe patient's clinical background. 79.3 84.0
47 Retrieval and interpretation of an accurate andcomprehensive drug history if and when required. 89.4 91.5
48 Identification of non-adherence and implementation ofappropriate patient intervention. 85.8 86.8
49 Ability to advise to physicians and—in somecases—prescribe medication. 80.7 87.6
Cluster 14. Patient
care competences:
drug interactions.
50
Identification, understanding and prioritization of
drug–drug interactions at a molecular level (e.g., use of
codeine with paracetamol).
91.8 91.6
51
Identification, understanding, and prioritization of
drug–patient interactions, including those that preclude
or require the use of a specific drug (e.g., trastuzumab for
treatment of breast cancer in women with HER2
overexpression).
87.7 89.7
52 Identification, understanding, and prioritization ofdrug–disease interactions (e.g., NSAIDs in heart failure). 94.5 96.6
Cluster 15. Patient
care competences:
provision of drug
product.
53
Familiarity with the bio-pharmaceutical,
pharmacodynamic and pharmacokinetic activity of a
substance in the body.
90.8 81.2
54
Supply of appropriate medicines taking into account
dose, correct formulation, concentration, administration
route and timing.
96.3 94.9
55 Critical evaluation of the prescription to ensure that it isclinically appropriate and legal. 94.1 94.0
56
Familiarity with the supply chain of medicines and the
ability to ensure timely flow of drug products to
the patient.
78.6 84.6
57 Ability to manufacture medicinal products that are notcommercially available. 69.0 60.5
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Table 3. Cont.
Cluster n Competence Academics CommunityPharmacists
Cluster 16. Patient
care competences:
patient education.
58 Promotion of public health in collaboration with otheractors in the healthcare system. 75.1 82.6
59 Provision of appropriate lifestyle advice on smoking,obesity, etc. 71.0 80.9
60 Provision of appropriate advice on resistance toantibiotics and similar public health issues. 89.4 93.1
Cluster 17. Patient
care competences:
provision of
information and
service.
61 Ability to use effective consultations to identify thepatient's need for information. 81.1 90.9
62 Provision of accurate and appropriate information onprescription medicines. 89.3 94.4
63
Provision of informed support for patients in selection
and use of non-prescription medicines for minor ailments
(e.g., cough remedies...).
89.4 94.0
Cluster 18. Patient
care competences:
monitoring of drug
therapy.
64
Identification and prioritization of problems in the
management of medicines in a timely manner and with
sufficient efficacy to ensure patient safety.
87.9 93.0
65
Ability to monitor and report to all concerned in a timely
manner, and in accordance with current regulatory
guidelines on Good Pharmacovigilance Practices (GVPs),
Adverse Drug Events and Reactions (ADEs and ADRs).
80.9 83.4
66
Undertaking of a critical evaluation of prescribed
medicines to confirm that current clinical guidelines are
appropriately applied.
81.6 80.6
Cluster 19. Patient
care competences:
evaluation of
outcomes.
67 Assessment of outcomes on the monitoring of patientcare and follow-up interventions. 73.7 79.0
68 Evaluation of cost effectiveness of treatment. 57.7 61.2
Notes: Competences in bold are those showing a statistically significant difference in distribution of rankings
between groups (chi-square, p < 0.05).
Both groups scored high for patient care competences (clusters 12–19). For competences linked to
drug research, development and production (clusters 7 and 11), results differed.
In cluster 7 (learning and knowledge), ranks were high (> 80% for 6 out of 7 competences).
Scores were lower for competence 6 (ability to design and conduct research using appropriate
methodology) and fell to 40% for community pharmacists. The latter proved to be more attached to
competencies connected with patient care, though this domain is less well defined and is missing
from the European directive. It is also susceptible to very different interpretations from one country to
another. Academics scored higher for competences related to science and research, i.e., competence 4
(capacity to evaluate scientific data in line with current scientific and technological knowledge) and
competence 6 (research).
For cluster 7, community pharmacists posted seven comments. This represented 0.4% of the
potential total number of comments (= 258 community pharmacists ˆ 7 propositions in cluster 7).
Comments on other propositions were equally low. Comments on cluster 7 concerned the practicality
of doing research “not always practical in a busy community setting”. Other points raised concerned
the access to scientific information from reliable sources “preselection of the new scientific information
by an official institute of continuing education is necessary” and “get essential information from reliable
sources”. Academics posted 12 comments (0.7% of potential total) often along the same lines
“impossible for a clinical practitioner to keep up to date with even a small area of therapeutics” and “they
are able to find synthesised forms of data (meta-analysis, systematic reviews) from trustworthy sources”.
Academics suggested that research concerned advanced studies “important for more scientifically oriented
pharmacists (Ph.D. students)”.
In cluster 8 (values) academics scored competence 10 (responsibility for patient care) lower than
did community pharmacists (88 versus 95%). This may be an indication of the lesser weight academics
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give to patient care. Albeit one academic commented “I consider a professional approach to patients and
their care as the absolute priority”. Overall there were eight comments from academics and four from
community pharmacists. One community pharmacist commented in relation to taking responsibility
“highly depends on how much information we have on patients”. Other limitations were raised such as that
from an academic “pharmacists can't take responsibility of patient's medication; in Finland this belongs to
doctors”. Another academic suggested that pharmacists should be able “whistle-blow and call out poor
practice of others”.
For two competences in cluster 9 (communication and organization) scores for academics and
community pharmacists were substantially different. For competence 18 (production of medicines)
academics score relatively high (60%), whereas less than half of community pharmacists (43%)
considered this important. Scores for competence 23 (entrepreneurship) were the opposite with
academics at 46% and community pharmacists at 64%. Comments centered on competence 18 “no
production of medicines, only dispensing”, and 21 (communication in English) “knowledge of English not
essential, knowledge of local language is essential”.
Cluster 10 (“competences” 24–37) on the science of medicines was included because the EU
Directive [15] lists these 14 subject areas. These are not competences as such but foundations of
competences [16]. The inclusion of these subjects provoked substantial misunderstanding with low
scores for “competences” concerned with biology (24) and physics (25). Chemistry and analytical
chemistry (27 and 28), and pharmaceutical technology (34) were ranked much higher by academics
than by community pharmacists. Pharmacology (32) and pharmacotherapy (33) received scores >90%
from both academics and community pharmacists.
Cluster 10 received the most comments—11 from academics and eight from community
pharmacists. Comments from academics centered on:
‚ Subjects
# “the heart of the job is human biology and physiopathology”
# Subjects to be added:
‚ pharmaceutical care
‚ clinical pharmacy
‚ basic clinical knowledge
‚ physiopathology
‚ social sciences
‚ statistics
‚ Level and job profile
# “they should also have a background in sciences in general”
# “differences may be in the level of knowledge for particular field on the way of professional
specialization, not for the pharmacist at the beginning of the career”
# “depends if we have to do with a pharmacist in hospital, industry, academy, government or local
pharmacies”
Comments from community pharmacists centered on:
‚ Subjects to be added:
‚ Pharmaceutical care
‚ business administration
‚ Level and job profile
# “being a pharmacist you need the basic knowledge of all the above area. Having a speciality will be
important depending the sector you are going to practice”
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# “all answers refer to daily work in community pharmacy”
Scores for competences in cluster 11 (industrial pharmacy) were high for academics (< 75%), but
lower for community pharmacists (< 65%). There were marked differences e.g., for competence 41
(drug registration): academics 72%, community pharmacists 56%. Comments centered on job profile,
with, for example, from academics: “not really the daily preoccupation of most pharmacists”, “some points
are essential for pharmacist in pharmaceutical industry, research and development, but it is of little importance
for other pharmacists”, and from community pharmacists “it's not my job”. Comments from academics
raised the point that all pharmacists should have knowledge of pharmaceutical production as a basis
for community practice, e.g., “must be able to understand the security reasons behind withdrawals to explain
them”. There was some confusion regarding competence 42 (good clinical practice), some applying this
to the drug research and development process, and others to community pharmacy practice.
Scores were generally high for clusters 12–19 with only one difference between academics
and community pharmacists. This was for competence 53 (familiarity with the bio-pharmaceutical,
pharmacodynamic and pharmacokinetic activity of a substance in the body) with academics scoring
higher than community pharmacists.
Comments concerned aspects such as diagnosis (competence 44) “one of the challenges that we
have come across with extending roles for pharmacists relates to body contact tests and invasive tests.
Should these be covered?” Other comments concerned prescription “I would regard it as essential
to be able to advise physicians, but currently it is not within the scope of practice for pharmacists
to prescribe.”
There were also comments on the level at which specific competence should be
taught—“competences in basic drug contraindications (drug-disease interactions) and knowledge of molecular
mechanism of drug-drug interactions must be excellent already when the student finishes the university. Clinical
relevance of drug-related problems plus conditions contributing to clinically significant drug-drug interactions,
side effects, etc. should be trained on postgraduate level.”
Scores for competence 57 (manufacture of products not commercially available) were low.
Comments centered on the fact that this activity has almost disappeared in most EU countries given
the introduction of stringent regulations on GMP: “manufacturing medicinal production is well under way
of near prohibition, with stringent regulations to insure GMP. Both a good point and a bad point, as this means
higher quality and controllability, but near industrial manufacturing units in a few selected drugstores, and a
specific class of pharmacists.”
This low score and that for cluster 11 reveals a low awareness amongst community pharmacists
that pharmacists are “medicines specialists” involved in the whole drug life cycle from R&D, through
production, quality assurance, registration, patient care, pharmaco-economics and post marketing
studies. This is not good for the pharmacy profession. Taken to extremes it may be concluded—based
on the opinion of community pharmacists—that there is no need to employ pharmacists in the
medicines industry.
Scores for cluster 16 (patient education) were high. Academics commented that “pharmacists have
a key role in offering public health/healthy living advice” with the proviso that “general information on diet or
exercise is important but the specific recommendations for the patient should be made by the experts in those
areas (f. ex. dietician or physiotherapist).”
Scores for cluster 17 (provision of information and service) were high. Comments centered on
“pharmacist should also provide information about medical devices and other items available in the pharmacy”,
and “need to ensure all information and products are evidence-based and appropriate for that patient.”
Scores for cluster 18 (monitoring of drug therapy) were high. Academics commented that “safety
and effectiveness are paramount—ensuring we learn from medication errors, post-marketing surveillance and
demonstrate clinical effectiveness.”
Scores for cluster 19 (evaluation of outcomes) were low. Academics commented that these
competences were in the domain of clinical or hospital pharmacy.
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There were several general comments on methodology, for example, on the use of idiomatic
English and phraseology. The construction of proposals with two or more points raised in one
question (e.g., for competence 23) also clouded the issue. These and other comments on practicalities
have been taken into consideration in the production of the revised version of the questionnaire.
Finally, comments throughout pointed to the esoteric nature of certain competences and the need for
recognition of specialization.
Concerning the age group sub-analysis, the scores for the age subgroups of academics are given
in Figure 1.
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Figure 1. Scores (%) for ankings of compete c ics over 40 (n = 1 4, solid line) and under
40 (n = 97, dotted line).
Chi-square revealed one difference only—that for competence 19 (quality of service) where
academics over 40 scored higher than those under 40. For competences 6, 18, 28, 38, and 40 where
there were major differences between academics and community pharmacists (see above), there
were no significant differences between the two age subgroups of academics. Overall these data
suggest that there is no evolution in the opinions, concerning the topics mentioned, of academics
with age. Furthermore the fact of having been exposed during their own education to concepts such
as “pharmaceutical care” and “competence for practice” (i.e., < 40 years of age) does not appear to
influence their rankings for patient care competences. Carrying on from this, it can be suggested that
the differences between academics and community pharmacists noted previously is not a question
of age.
The above results can be understood very negatively, i.e., what academics learn d 25 years ago
they cons der is still valid. The study is cross-sectional and measures what ac demics > 40 think today,
not wh t they thought 25 years ago. There is probably no difference with age due to evolution of
opinions according to the state of the art in the field: evidence-based pharmacy influences opinions of
academics regardless of age.
The scores for the age subgroups of community pharmacists are given in Figure 2.
Chi-square revealed one difference only—that for competence 41 (drug registration) where
community pharmacists under 40 scored higher than those over 40; otherwise there were no statistically
significant differences. It is to be noted that for the 7–17 competences concerning values and
communication, as well as in the group 60–65 concerning again the relation with patients, young
pharmacists were somewhat less enthusiastic than their elder colleagues, in spite of the clear movement
of community pharmacy practice in this direction. For competences 6, 18, 28, 38, and 40 where there
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were major differences between community pharmacists and academics (see above), there were no
significant differences between the two age subgroups of community pharmacists. Overall these data
suggest that there is no evolution in the opinions of community pharmacists with age.
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4. Conclusions
While surveys of pharmacist perceptions of competence standards have been carried out
elsewhere, for example in Thailand [17], to our knowledge, this is the first such survey on a large
scale in Europe, although a similar study on competences for medical doctors has been published
by MEDINE. Many techniques can be used to identify competencies for practice. Grussing [18] has
suggested using multiple methods such as generation by a panel, validation by practitioner surveys or
by job analysis. We used the first two of these: generation of a proposal for competences by a panel of
experts followed by validation on a large, European-wide scale. We suggest that this double approach
strengthens the recommendations of the PHAR-QA consortium.
The general message of this PHAR-QA study is that both academics and community pharmacist
recognize the importance of the notion of patient care, as reflected by the high scores for patient care
competences. The rankings and the comments underline the nature of the pharmacist as a specialist of
medicines, capable making critical evaluations on therapy, and advising the patient as to the best use
of medicines.
Community pharmacists gave low scores to drug research, development and production, in spite
of the fact that, historically, these domains are the building blocks of pharmacy. As far as research is
concerned, this low score is not reflected in the opinions of other healthcare professionals. Thus in the
MEDINE2 study on competences for medical practice, medical doctors thought that “learning outcomes
related both to ‘using research’ and ‘doing research’ should be core components of medical curricula”.
In other studies the message is more equivocal. In the Elvey et al. [19] study (Who do you Think
You Are? Pharmacists’ Perceptions of Their Professional Identity), the authors asked professional
pharmacists to give their opinions on nine possible professional identities. They concluded that “While
the scientist was the strongest professional identity to emerge it nevertheless seemed to overlap and
compete with other professional identities . . . ”
This leads on to the question asked by Waterfield [20]: “Is pharmacy a knowledge-based profession?”
Waterfield concludes that “The closer integration of science and practice is another area that needs to be
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considered by educators as they consider the place of practice-based knowledge.” They stress the importance
of the place of science in pharmacy curricula and practice. The future challenge will be to instill a
sense of science-based practice into the mind of the practizing pharmacist, and this via both pre- and
postgraduate (continuous professional development) education.
The PHAR-QA study raises the point of specialization in pharmacy education. The nature and
depth of the subjects to be dealt with varies as a function of the orientation for a given professional
practice. Several comments suggested that competences dealing with research, industrial pharmacy,
and pharmaceutical technology belong to specialized, postgraduate education for industrial pharmacy.
Competences related to assessment of outcomes and monitoring of patient care; these were considered
to be in the domain of a hospital pharmacy specialization.
5. Perspectives
In the light of the rankings and comments, a revised version of the survey on the competence
framework was produced [21]. This second round will be followed by the publication of a PHAR-QA
competence framework for pharmacy practice. Using the PHAR-QA competence framework it will be
possible to compare attitudes with the emphases of the same categories in current pharmacy school
curricula. Thus suggestions could be made for change in such curricula to address what seems to be a
shifting preference of emphasis.
The PHAR-QA competence framework could be incorporated into pharmacy education at various
levels of Miller’s triangle [22]. This triangle describes a conceptual, pyramidal model of the various
facets of competence with four levels, from level 1 “knows” to level 4 “does”. Given the low
scores of most of the subject areas (cluster 10), it would appear that academics and community
pharmacists do not grasp the importance of level 1 subjects as building blocks of the level 2
competences. The PHAR-QA framework could be used to develop integrated, coordinated courses
that combine several subjects under a broad competence heading. Another use of the PHAR-QA
competence framework could be the accreditation at level 2 “knows how”. This would allow a realistic
evaluation of a student’s ability to synthesize different subjects into comprehensive competences.
The PHAR-QA framework could also be used at the third level in the performance testing of students.
Patient substitutes could present students with elements such as symptoms, prescriptions, etc. calling
upon PHAR-QA competences to solve problems related to drug interaction and other aspects.
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